JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 9 1617-1620
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhatnagar, A.
Right arrow Articles by Ziessman, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhatnagar, A.
Right arrow Articles by Ziessman, H. A.

Technetium-99m-Sestamibi Parathyroid Scintigraphy: Effect of P-Glycoprotein, Histology and Tumor Size on Detectability

Anish Bhatnagar, Phyllis R. Vezza, John A. Bryan, Francis B. Atkins and Harvey A. Ziessman

Division of Nuclear Medicine, Departments of Radiology and Pathology, Georgetown University Hospital, Washington, D.C.

Correspondence: For correspondence or reprints contact: Harvey A. Ziessman, MD. Georgetown University Hospital, Division of Nuclear Medicine, 3800 Reservoir Rd., NW, #2005 Gorman, Washington, DC 20007.

ABSTRACT

The purpose of this study was to evaluate the effect of P-glycoprotein (P-gp) levels, predominant histology and tumor size on the detectability of parathyroid adenomas with 99mTc-sestamibi scans. Although previous studies have shown that positivity correlates with tumor size, false-negative studies have been reported with large tumors and true-positives reported with very small tumors. Recent investigations have reported rapid washout of sestamibi in malignant tumors because of high levels of P-gp, similar to that seen with multidrug chemotherapy resistance. Therefore, we postulated that this mechanism might account for false-negative studies in parathyroid tumors. Preliminary reports have suggested that the predominant histological subtype influences positivity on 99mTc-sestamibi parathyroid scans. Methods: We studied 25 patients with surgically confirmed parathyroid adenomas with 99mTc-sestamibi parathyroid scans. The results of the imaging study were corralated with tissue P-gp levels, predominant histological subtype and size of the surgically removed glands. Results: There were 21 true-positive and 4 false-negative results. The size of the adenomas ranged from 0.12 to 8.64 ml. We found no correlation between the results of the dual-phase 99mTc-sestamibi study and either the predominant cell type or the level of P-gp. Positivity did correlate with the size of the adenoma (p = 0.73, p < 0.0001). We cannot exclude the possibility that P-gp and cell type may still play a role in individual cases, but we suspect that other yet to be determined factors may influence 99mTc-sestamibi detectability in addition to tumor size.

Key Words: parathyroid • p-glycoprotein • histology • volume




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Takeuchi, N. C. Greep, D. S. B. Hoon, A. E. Giuliano, N. M. Hansen, N. Umetani, and F. R. Singer
Hypermethylation of Adenosine Triphosphate-Binding Cassette Transporter Genes in Primary Hyperparathyroidism and Its Effect on Sestamibi Imaging
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1785 - 1790.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
N. Y. Mehta, J. M. Ruda, S. Kapadia, P. J. Boyer, C. S. Hollenbeak, and B. C. Stack Jr
Relationship of Technetium Tc 99m Sestamibi Scans to Histopathological Features of Hyperfunctioning Parathyroid Tissue
Arch Otolaryngol Head Neck Surg, June 1, 2005; 131(6): 493 - 498.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
O. Ugur, M. F. Bozkurt, E. Hamaloglu, C. Sokmensuer, I. Etikan, Y. Ugur, I. Sayek, and S. A. Gulec
Clinicopathologic and Radiopharmacokinetic Factors Affecting Gamma Probe-Guided Parathyroidectomy
Arch Surg, November 1, 2004; 139(11): 1175 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kawata, M. Kanai, T. Sasada, S. Iwata, N. Yamamoto, and A. Takabayashi
Usefulness of 99mTc-Sestamibi Scintigraphy in Suggesting the Therapeutic Effect of Chemotherapy against Gastric Cancer
Clin. Cancer Res., June 1, 2004; 10(11): 3788 - 3793.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Mariani, S. A. Gulec, D. Rubello, G. Boni, M. Puccini, M. R. Pelizzo, G. Manca, D. Casara, G. Sotti, P. Erba, et al.
Preoperative Localization and Radioguided Parathyroid Surgery
J. Nucl. Med., September 1, 2003; 44(9): 1443 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Gorlick, A. C. Liao, C. Antonescu, A. G. Huvos, J. H. Healey, R. Sowers, M. Daras, E. Calleja, L. H. Wexler, D. Panicek, et al.
Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma
Clin. Cancer Res., October 1, 2001; 7(10): 3065 - 3070.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.